Leave a legacy as unique as they are.

No two patients are exactly alike, but with the TECNIS® Multifocal Family of IOLs, you can give your patients excellent outcomes distinctly suited to their lifestyle. Each lens delivers a full range of the sharpest vision, enhanced functionality and long-term sustainability.


The TECNIS® Multifocal Family of IOLs are the only multifocal IOLs capable of providing high-quality vision (20/25) throughout the full range of vision: distance, intermediate and near1

Superior image contrast2


2X HIGHER IMAGE CONTRAST at near distance in normal light (3mm pupil) compared to AcrySof® IQ ReSTOR® +2.5 D IOLs2

Modular Transfer Function (MTF) is a measure of the amount of contrast transferred by the optics in a visual system. The higher the MTF value, the more contrast transferred to the image, resulting in higher image contrast.

AcrySof is a trademark of Novartis AG Corp.


3X HIGHER IMAGE CONTRAST at near distance in low light (5mm pupil) compared to AcrySof® IQ ReSTOR® +3.0 D IOLs2
4X HIGHER IMAGE CONTRAST AT NEAR DISTANCE in low light (5mm pupil) compared to AcrySof® IQ ReSTOR® +2.5 D IOLs2


Best spectacle independence in any lighting condition1

  • All TECNIS® Multifocal Lenses provide significantly increased overall spectacle independence1

All TECNIS® Multifocal Lenses provide significantly INCREASED OVERALL SPECTACLE INDEPENDENCE1

>90% of TECNIS® Multifocal +2.75 D patients report no difficulty with night vision*1

A full diffractive posterior surface makes the optic pupil-independent, especially important for low‑light conditions


Unlike another leading IOL, TECNIS® IOL material is not associated with glistenings3-5

  • Glistenings cause light scatter, which can result in a reduction in image contrast5,6

High patient satisfaction1


With the TECNIS® Family of IOLs, you can give each patient a full range of the sharpest vision with enhanced focus where they’ll use it most. Each lens is optimized for peak performance at one of three strategic distances based on varying visual demands.

Tecnis Multifocal 4.0D

Tecnis Multifocal 4.0D

Optimized for near vision
Vision Activities: Reading, fine detail work
Theoretical Reading Distance: 33 cm


Tecnis Multifocal 3.25D

Tecnis Multifocal 3.25D

Optimized for longer reading distances
Vision Activities: Multimedia work
Theoretical Reading Distance: 42 cm


Tecnis Multifocal 2.75D

Tecnis Multifocal 2.75D

Optimized for intermediate vision
Vision Activities: Golfing, grocery shopping
Theoretical Reading Distance: 50 cm


* On a scale of 1-7. TECNIS® Multifocal 1-Piece Low Add DFU. Abbott Medical Optics Inc., Santa Ana, Calif.


Rx Only


Reference the Directions for Use for a complete listing of Indications and Important Safety Information.


AMO TECNIS® 1-Piece Lenses are indicated for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by extra capsular cataract extraction. These devices are intended to be placed in the capsular bag.


Physicians considering lens implantation under any of the conditions described in the Directions for Use should weigh the potential risk/benefit ratio prior to implanting a lens. Some visual effects associated with multifocal IOLs may be expected because of the superposition of focused and unfocused images. These may include a perception of halos/glare around lights under nighttime conditions. It is expected that, in a small percentage of patients, the observation of such phenomena will be annoying and may be perceived as a hindrance, particularly in low illumination conditions. On rare occasions, these visual effects may be significant enough that the patient will request removal of the multifocal IOL. Contrast sensitivity is reduced with a multifocal lens compared to a monofocal lens. Therefore, patients with multifocal lenses should exercise caution when driving at night or in poor visibility conditions. Patients with a predicted postoperative astigmatism >1.0D may not be suitable candidates for multifocal IOL implantation since they may not fully benefit from a multifocal IOL in terms of potential spectacle independence. Care should be taken to achieve centration, as lens decentration may result in patients experiencing visual disturbances, particularly in patients with large pupils under mesopic conditions. Multifocal IOL implants may be inadvisable in patients where central visual field reduction may not be tolerated, such as macular degeneration, retinal pigment epithelium changes, and glaucoma. Patients with certain medical conditions may not be suitable candidates for IOLs. Consult the Directions for Use for more information.


Prior to surgery, the surgeon must inform prospective patients of the possible risks and benefits associated with the use of this device and provide a copy of the patient information brochure to patient. There were no patients 21 years old or younger included in the clinical studies; therefore there are insufficient clinical data to demonstrate safety and effectiveness in this age group. The central one millimeter area of the lens creates a far image focus, therefore patients with abnormally small pupils (~1mm) should achieve, at a minimum, the prescribed distance vision under photopic conditions; however, because this multifocal design has not been tested in patients with abnormally small pupils, it is unclear whether such patients will derive any near vision benefit. Autorefractors may not provide optimal postoperative refraction of multifocal patients; manual refraction is strongly recommended. In contact lens wearers, surgeons should establish corneal stability without contact lenses prior to determining IOL power. Care should be taken when performing wavefront measurements as two different wavefronts are produced (one will be in focus (either far or near) and the other wavefront will be out of focus); therefore incorrect interpretation of the wavefront measurements is possible. The long-term effects of intraocular lens implantation have not been determined; therefore implant patients should be monitored postoperatively on a regular basis. Secondary glaucoma has been reported occasionally in patients with controlled glaucoma who received lens implants. The intraocular pressure of implant patients with glaucoma should be carefully monitored postoperatively. Do not resterilize or autoclave. Use only sterile irrigating solutions such as balanced salt solution or sterile normal saline. Do not store in direct sunlight or over 45°C (113°). Emmetropia should be targeted as this lens is designed for optimum visual performance when emmetropia is achieved. Please refer to the specific instructions for use provided with the insertion instrument or system for the amount of time the IOL can remain folded before the IOL must be discarded. When the insertion system is used improperly, the haptics of the IOL may become broken. Please refer to the specific instructions for use provided with the insertion instrument or system.


The most frequently reported adverse event that occurred during the clinical trials of the TECNIS® Multifocal lenses was surgical re-intervention, most of which were non-lens-related. Lens-related re-interventions occurred at a rate of 0.6% to 1.0%. Other surgical re-interventions included lens exchanges (for incorrect IOL power), retinal repair, ruptured globe repair, macular hole repair, removal of retained lens material, treatment injections for cystoid macular edema and iritis, and blepharoplasty.


  1. TECNIS® Multifocal 1-Piece IOL DFU. Santa Ana, Calif. Abbott Medical Optics Inc.
  2. Data on File, Abbott Medical Optics Inc., 2015.
  3. Data on File, Abbott Medical Optics Inc., 2013.
  4. Hayashi K, et al. Long-term effect of surface light scattering and glistenings of intraocular lenses on visual function. J Ophthalmol Am. 2012 Aug;154(2):240-251.
  5. Nagata M, et al. Clinical evaluation of the transparency of hydrophobic acrylic intraocular lens optics. J Cataract Refract Surg. 2010 Dec;36(12):2056-60.
  6. Van der Mooren M, Franssen L, Piers P. Effects of glistenings in intraocular lenses. Biomed Opt Express. 2013 Jul 11;4(8):1294-304